GLPG logo

Galapagos NV (GLPG) Company Overview

Profile

Full Name:

Galapagos NV

Sector:

Healthcare

Industry:

Biotechnology

Country:

Belgium

IPO:

February 27, 2012

Indexes:

Not included

Description:

Galapagos NV is a biotechnology company focused on discovering and developing new medicines. They work on innovative treatments for diseases, particularly in areas like inflammation and fibrosis. Their goal is to improve patient health through advanced research and drug development.

Key Details

Price

$26.06

Annual Revenue

$298.35 M(+14.96% YoY)

Annual EPS

$1.21(-65.12% YoY)

Beta

0.49

Events Calendar

Earnings

Next earnings date:

Apr 23, 2025

Recent quarterly earnings:

Feb 12, 2025

Recent annual earnings:

Feb 12, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 14, 25 Morgan Stanley
Underweight
Jan 23, 25 Barclays
Underweight
Nov 1, 24 RBC Capital
Sector Perform
Sep 9, 24 Leerink Partners
Market Perform
Apr 22, 24 Morgan Stanley
Equal-Weight
Apr 1, 24 B of A Securities
Underperform
Mar 28, 24 B of A Securities
Underperform
Jan 2, 24 B of A Securities
Neutral
Aug 7, 23 Morgan Stanley
Equal-Weight
Aug 1, 23 Morgan Stanley
Equal-Weight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Galapagos NV?
  • Does Galapagos NV pay dividends?
  • What sector is Galapagos NV in?
  • What industry is Galapagos NV in?
  • What country is Galapagos NV based in?
  • When did Galapagos NV go public?
  • Is Galapagos NV in the S&P 500?
  • Is Galapagos NV in the NASDAQ 100?
  • Is Galapagos NV in the Dow Jones?
  • When was Galapagos NV's last earnings report?
  • When does Galapagos NV report earnings?

What is the ticker symbol for Galapagos NV?

The ticker symbol for Galapagos NV is NASDAQ:GLPG

Does Galapagos NV pay dividends?

No, Galapagos NV does not pay dividends

What sector is Galapagos NV in?

Galapagos NV is in the Healthcare sector

What industry is Galapagos NV in?

Galapagos NV is in the Biotechnology industry

What country is Galapagos NV based in?

Galapagos NV is headquartered in Belgium

When did Galapagos NV go public?

Galapagos NV's initial public offering (IPO) was on February 27, 2012

Is Galapagos NV in the S&P 500?

No, Galapagos NV is not included in the S&P 500 index

Is Galapagos NV in the NASDAQ 100?

No, Galapagos NV is not included in the NASDAQ 100 index

Is Galapagos NV in the Dow Jones?

No, Galapagos NV is not included in the Dow Jones index

When was Galapagos NV's last earnings report?

Galapagos NV's most recent earnings report was on Feb 12, 2025

When does Galapagos NV report earnings?

The next expected earnings date for Galapagos NV is Apr 23, 2025